-
1
-
-
0037387501
-
Cross-reacting drugs and chemicals
-
Woessner K. Cross-reacting drugs and chemicals. Clin Rev Allergy Immunol. 2003;24:149-158.
-
(2003)
Clin Rev Allergy Immunol
, vol.24
, pp. 149-158
-
-
Woessner, K.1
-
2
-
-
0036676087
-
The safety of celecoxib in aspirin exacerbated respiratory disease
-
Woessner K, Simon RA, Stevenson DD. The safety of celecoxib in aspirin exacerbated respiratory disease. Arthritis Rheum. 2002;46:2201-2206.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2201-2206
-
-
Woessner, K.1
Simon, R.A.2
Stevenson, D.D.3
-
3
-
-
0034924476
-
Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients
-
Stevenson D, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J Allergy Clin Immunol. 2001;108:47-51.
-
(2001)
J Allergy Clin Immunol
, vol.108
, pp. 47-51
-
-
Stevenson, D.1
Simon, R.A.2
-
4
-
-
3042765340
-
Sensitivity to aspirin and NSAIDs
-
Adkinson NJ, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simon FE, editors. Philadelphia, PA: CV Mosby and Co.
-
Stevenson D, Simon RR, Zuraw BL. Sensitivity to aspirin and NSAIDs. In: Adkinson NJ, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simon FE, editors. Allergy Principles and Practice, 6th ed. Philadelphia, PA: CV Mosby and Co; 2003:1695-1710.
-
(2003)
Allergy Principles and Practice, 6th Ed.
, pp. 1695-1710
-
-
Stevenson, D.1
Simon, R.R.2
Zuraw, B.L.3
-
5
-
-
0020055511
-
Aspirin in chronic urticaria and/or angioedema: Studies of sensitivity and desensitization
-
Mathison DA, Lumry WR, Stevenson DD. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol. 1982;69:135.
-
(1982)
J Allergy Clin Immunol
, vol.69
, pp. 135
-
-
Mathison, D.A.1
Lumry, W.R.2
Stevenson, D.D.3
-
6
-
-
0016662061
-
Reactions to aspirin and food additives in patients with chronic urticaria, including physical urticaria
-
Doeglas H. Reactions to aspirin and food additives in patients with chronic urticaria, including physical urticaria. Br J Dermatol. 1975;93:135-143.
-
(1975)
Br J Dermatol
, vol.93
, pp. 135-143
-
-
Doeglas, H.1
-
7
-
-
0019287331
-
Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors
-
Gibson A, Clancy R. Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors. Clin Allergy. 1980;10:699-705.
-
(1980)
Clin Allergy
, vol.10
, pp. 699-705
-
-
Gibson, A.1
Clancy, R.2
-
9
-
-
0348134796
-
Safety of COX-2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to NSAIDs
-
Zembowicz AM, Setkowicz M, Radziszewski W, Szczeklik A. Safety of COX-2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to NSAIDs. Arch Dermatol. 2003;139:1577-1582.
-
(2003)
Arch Dermatol
, vol.139
, pp. 1577-1582
-
-
Zembowicz, A.M.1
Setkowicz, M.2
Radziszewski, W.3
Szczeklik, A.4
-
10
-
-
1942500163
-
Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma
-
Mastalerz LS, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004;113:771-775.
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 771-775
-
-
Mastalerz, L.S.1
Sanak, M.2
Szczeklik, A.3
-
11
-
-
0038404910
-
Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria
-
Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol. 2003;111:1095-1098.
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 1095-1098
-
-
Asero, R.1
-
12
-
-
6044264974
-
Safety of the new selective cyclooxygenase 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reaction to nonsteroidal anti-inflammatory drugs
-
Quiralte J, Delgado J, Saenz de San Pedro B, et al. Safety of the new selective cyclooxygenase 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reaction to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2004;93:360-364.
-
(2004)
Ann Allergy Asthma Immunol
, vol.93
, pp. 360-364
-
-
Quiralte, J.1
Delgado, J.2
Saenz De San Pedro, B.3
-
13
-
-
12344335531
-
Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs
-
Nettis E, Colanardi MC, Ferrannini A, Tursi A. Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2005;94:29-33.
-
(2005)
Ann Allergy Asthma Immunol
, vol.94
, pp. 29-33
-
-
Nettis, E.1
Colanardi, M.C.2
Ferrannini, A.3
Tursi, A.4
-
14
-
-
12344287988
-
Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib
-
Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol. 2005;94:34-38.
-
(2005)
Ann Allergy Asthma Immunol
, vol.94
, pp. 34-38
-
-
Sanchez-Borges, M.1
Caballero-Fonseca, F.2
Capriles-Hulett, A.3
-
15
-
-
0016320119
-
IgE and non-IgE mediated allergic type reactions to aspirin
-
Phils JA, Perlmutter L. IgE and non-IgE mediated allergic type reactions to aspirin. Acta Allergol. 1974;29:474-481.
-
(1974)
Acta Allergol
, vol.29
, pp. 474-481
-
-
Phils, J.A.1
Perlmutter, L.2
-
16
-
-
0019470109
-
Investigation of the possible involvement of IgE antisalicylol antibodies in patients with urticaria
-
Krilis S, Gregson RP, Basten A. Investigation of the possible involvement of IgE antisalicylol antibodies in patients with urticaria. Int Arch Allergy Appl Immunol. 1981;64:293-300.
-
(1981)
Int Arch Allergy Appl Immunol
, vol.64
, pp. 293-300
-
-
Krilis, S.1
Gregson, R.P.2
Basten, A.3
-
17
-
-
0036168932
-
Urticaria and angioedema induced by COX-2 inhibitors
-
Grimm V, Rakoski J. Urticaria and angioedema induced by COX-2 inhibitors. J Allergy Clin Immunol. 2002;109:370.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 370
-
-
Grimm, V.1
Rakoski, J.2
-
18
-
-
0036200326
-
Anaphylaxis to celecoxib
-
Grob MP, Wuthrich B. Anaphylaxis to celecoxib. Allergy. 2002;57:264-265.
-
(2002)
Allergy
, vol.57
, pp. 264-265
-
-
Grob, M.P.1
Wuthrich, B.2
-
22
-
-
0034857046
-
Rofecoxib: Safe in NSAID intolerant patients
-
Berges-Gimeno M, Camacho-Garrido E, Garcia-Rodriguez RM, Martin-Garcia C, Alfaya T, Hinojosa M. Rofecoxib: safe in NSAID intolerant patients. Eur J Allergy Clin Immunol. 2001;56:1017-1018.
-
(2001)
Eur J Allergy Clin Immunol
, vol.56
, pp. 1017-1018
-
-
Berges-Gimeno, M.1
Camacho-Garrido, E.2
Garcia-Rodriguez, R.M.3
Martin-Garcia, C.4
Alfaya, T.5
Hinojosa, M.6
-
23
-
-
0036228229
-
Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs
-
Pacor M, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R. Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy. 2002;32:397-400.
-
(2002)
Clin Exp Allergy
, vol.32
, pp. 397-400
-
-
Pacor, M.1
Di Lorenzo, G.2
Biasi, D.3
Barbagallo, M.4
Corrocher, R.5
-
24
-
-
0036127939
-
Tolerability of rofecoxib in patient with cutaneous adverse reactions to NSAIDs
-
Nettis ED, Ferrannini A, Tursi A. Tolerability of rofecoxib in patient with cutaneous adverse reactions to NSAIDs. Ann Allergy Asthma Immunol. 2002;88:331-334.
-
(2002)
Ann Allergy Asthma Immunol
, vol.88
, pp. 331-334
-
-
Nettis, E.D.1
Ferrannini, A.2
Tursi, A.3
-
25
-
-
0029005688
-
The effect of aspirin desensitization on urinary leukotriene E4 concentration in aspirin-sensitive asthma
-
Nasser SM, Patel M, Bell GS, Lee TH. The effect of aspirin desensitization on urinary leukotriene E4 concentration in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1995;151:1326-1330.
-
(1995)
Am J Respir Crit Care Med
, vol.151
, pp. 1326-1330
-
-
Nasser, S.M.1
Patel, M.2
Bell, G.S.3
Lee, T.H.4
-
26
-
-
0036666451
-
Safety of selective cyclooxgenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions
-
Quiralte J, Saenz de San Pedro B, Florido JJ. Safety of selective cyclooxgenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions. Ann Allergy Asthma Immunol. 2002;89:63-66.
-
(2002)
Ann Allergy Asthma Immunol
, vol.89
, pp. 63-66
-
-
Quiralte, J.1
Saenz De San Pedro, B.2
Florido, J.J.3
-
27
-
-
0034866095
-
Tolerability of rofecoxib
-
Asero R. Tolerability of rofecoxib. Allergy. 2001;56:916-917.
-
(2001)
Allergy
, vol.56
, pp. 916-917
-
-
Asero, R.1
|